This page shows the latest chronic diseases news and features for those working in and with pharma, biotech and healthcare.
There are more than 100 chronic autoimmune diseases, many of which are severely debilitating, and some life-threatening. ... Having demonstrated pre-clinical efficacy in multiple autoimmune diseases, EVOQ is enthusiastic to work closely with JDRF on type
The Janssen Pharmaceutical Companies of Johnson &Johnson (Janssen) have shared results from a real-world study evaluating the use of Imbruvica (ibrutinib) in patients with chronic lymphocytic leukaemia (CLL). ... Insights from real-world data are
central drivers of the type 2 inflammation that plays a major role in multiple related – and often co-morbid – diseases. ... As one of the most common chronic diseases in children, asthma is a lung condition which, depending on its severity, can
AQ280 is a super selective Janus kinase 1 (JAK1) small molecule inhibitor that is under development for indications in the chronic inflammatory disease area. ... We now have] a pipeline with an innovative profile and a clear focus within chronic
This problem is estimated to affect around 250 million people globally suffering from chronic lung diseases. ... VisionHealth created the Kata app with the goal of guiding the inhalation process for patients suffering from chronic respiratory diseases
As a global leader in developing treatments for those living with chronic neurological and neurodegenerative diseases, Biogen is able to reinforce support for the new MS platform, which involves contributing educational
More from news
Approximately 2 fully matching, plus 200 partially matching documents found.
Remarkable advances in oncology technologies continue to provide hope that we may one day manage all cancers as chronic diseases.
Approximately 50% of patients with chronic diseases requiring maintenance self-medications do not take them in a prescribed way. ... Chronic therapies. No observable benefit in prophylactic treatments or even observed side effects.
By Tom York. The demand for NHS diagnostic services is increasing and so is the prevalence of chronic disease. ... Building the infrastructure and pathways to facilitate these technologies will be a vital component to improving the care for trial
Immune-mediated inflammatory diseases (IMIDs) provide a good example here. Due to the nature of some chronic diseases, and people’s varying capacity to adapt to them, the impact of an ... By better understanding how chronic diseases affect different
organisation. In immunology, we’re reframing clinical trials, drug development, and support networks for patients suffering with chronic skin conditions and other diseases. ... At Janssen, the patient voice is central to pursuing novel research and
More from intelligence
Approximately 2 fully matching, plus 64 partially matching documents found.
She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.
The company's Biopump uses a patient's own tissue to continuously produce and deliver their protein therapy and, potentially, has applications in a range of chronic diseases, including diabetes, multiple
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Healthcare systems around the world are already struggling to meet the demands of an ageing population, the rising incidence of chronic diseases, escalating healthcare costs and a deficit of healthcare workers. ... For example, in the United States (US)
In each of these types of research, the value-add is clear; pharmaceutical organisations can bring new drugs to market to treat or cure chronic and acute diseases more efficiently, making ... Inform the design of people-centred products which improve
Read on to learn about:. An interview with Professor Francesco Dazzi, Medical Lead Cell Therapy, BioPharmaceuticals R&D at AstraZeneca, on the company’s novel cell therapy pipeline for chronic diseases. ... Patient and market access insights on
Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and opportunities for biopharmaceutical companies
quality of life for people with Parkinson's and other chronic conditions.
More from PMHub
Approximately 6 fully matching, plus 38 partially matching documents found.
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...